| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Radiation Oncology [M. W. D.], Cancer Center [D. A. S., J. L. P.], and Division of Animal Resources [S. W., D. D.], University of Arizona Health Sciences Center, Tucson, Arizona 85724
Most early-phase testing of new therapeutic modalities involves analysis of initial tumor response as opposed to estimation of long-term response. In this study, the validity of initial response rates to predict long-term responses was examined for tumors treated with radiotherapy alone compared with heat combined with radiotherapy.
A total of 130 pet animals with either squamous cell carcinomas, melanomas, fibrosarcomas, mammary adenocarcinomas, or mast cell sarcomas were randomized to receive either radiation alone (XRT) or heat + radiation (
+ XRT). Responses to treatment were evaluated by response rates and response duration.
The complete response (CR) rates were consistently higher for
+ XRT than for XRT across different histology groups. The combined therapy led to prolonged tumor response in all histological subgroups except melanomas, which had a longer response duration when treated with XRT alone (p = 0.043). This was in spite of a relatively high CR rate in that group (100% versus 12.5% for
+ XRT and XRT, respectively). In contrast, while no significant improvement in CR rate was observed for dermal squamous cell carcinomas treated with
+ XRT (XRT = 52.9%;
+ XRT = 68.8%), a significant improvement in response duration was noted (p = 0.002). These are two examples where CR rate did not predict long-term response.
When all histological subgroups were combined (except melanomas), the CR rate was higher (p < 0.001), and response duration was prolonged (p = 0.031) for
+ XRT compared to XRT alone.
1 This work was supported by grants from the NIH-National Cancer Institute CA17343 and CA23074. Presented at the 24th Annual Meeting of the American Society of Therapeutic Radiologists, Orlando, Fla., October 25 to 29, 1982.
2 To whom requests for reprints should be addressed.
Received 11/24/82. Accepted 8/26/83.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |